Santiago v. Walgreen Co. et al
| Andrea Santiago |
| Walgreen Co, Walgreens Boots Alliance, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim U.S.A. Corporation, GlaxoSmithkline LLC, GlaxoSmithKline Holdings (Americas) Inc and Pfizer Inc |
| 9:2024cv80123 |
| February 2, 2024 |
| US District Court for the Southern District of Florida |
| Bruce E Reinhart |
| Robin L Rosenberg |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 Diversity-Petition for Removal |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 13, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 37
PRETRIAL ORDER # 80 Procedures for the Filing of All Future Claims in this MDL. Case is administratively closed and stayed. Signed by Judge Robin L. Rosenberg on 2/2/2024. See attached document for full details. (jas)
|
| Filing 36 MDL Transfer In Case Receipt from District of Northern District of Illinois. Case Number 23-cv-13951 with documents 1-33. Assigned FLSD Case Number 24-cv-80123. Re: FLSD MDL Case Number 20-md-2924. Clerks Note: JPML notified (jas) |
| Filing 35 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Bruce E. Reinhart. (jas) |
| Filing 34 Case transferred in from Illinois Northern; Case Number 1:23-cv-13951. Electronic file including transfer order and docket sheet received. .(jas). |
| Filing 33 TRANSFERRED to the Southern District of Florida the electronic record. (daj, ) |
| Filing 32 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to the Southern District of Florida. (daj, ) |
| ***Civil Case Terminated. (daj, ) |
| Filing 31 MINUTE entry before the Honorable Elaine E. Bucklo: The Court has reviewed the parties' joint status report. Pending the JPML decision, Status hearing is reset for 3/11/2024 at 9:45 a.m. (to track the case only, no appearance is required). The parties shall file a joint status report by 3/4/2024 and the court will enter an appropriate order. Mailed notice. (mgh, ) |
| Filing 30 STATUS Report JOINT STATUS REPORT REGARDING CONDITIONAL TRANSFER TO ZANTAC MULTIDISTRICT LITIGATION by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc. (Zousmer, Julia) |
| Filing 29 ANNUAL REMINDER: Pursuant to #Local Rule 3.2 (Notification of Affiliates)#, any nongovernmental party, other than an individual or sole proprietorship, must file a statement identifying all its affiliates known to the party after diligent review or, if the party has identified no affiliates, then a statement reflecting that fact must be filed. An affiliate is defined as follows: any entity or individual owning, directly or indirectly (through ownership of one or more other entities), 5% or more of a party. The statement is to be electronically filed as a PDF in conjunction with entering the affiliates in CM/ECF as prompted. As a reminder to counsel, parties must supplement their statements of affiliates within thirty (30) days of any change in the information previously reported. This minute order is being issued to all counsel of record to remind counsel of their obligation to provide updated information as to additional affiliates if such updating is necessary. If counsel has any questions regarding this process, this #LINK# will provide additional information. Signed by the Executive Committee on 12/28/2023: Mailed notice. (tg, ) |
| Filing 28 MINUTE entry before the Honorable Elaine E. Bucklo: The Court has reviewed the parties' joint status report. Pending the JPML decision, Status hearing is reset for 1/29/2024 at 9:45 a.m. (to track the case only, no appearance is required). The parties shall file a joint status report by 1/22/2024 and the court will enter an appropriate order. Mailed notice. (mgh, ) |
| Filing 27 STATUS Report by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc. (Zousmer, Julia) |
| Filing 26 MINUTE entry before the Honorable Elaine E. Bucklo: Defendants' motion for extension of time #20 is granted. Defendants' response to plaintiff's motion to remand due 10 days after the JPML vacates its conditional transfer order. Ruling set for 11/15/2023 is stricken. Mailed notice. (mgh, ) |
| Filing 25 RESPONSE by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc.in Opposition to MOTION by Plaintiff Andrea Santiago to remand and Memorandum of Law #16 REMOVING DEFENDANTS' OPPOSITION TO PLAINTIFF'S MOTION TO REMAND (Attachments: #1 Exhibit A - CTO-119, #2 Exhibit B - 5.18.23 CMO, #3 Exhibit C - 7.19.23 Order Continuing CMC, #4 Exhibit D - 4.13.23 Retailer Defendants MTD, #5 Exhibit E - 4.13.23 Brand Defendants MTD, #6 Exhibit F - 9.20.23 Brand Defendants Motion for Partial Dismissal of 1st Amended Master Complaint)(Zousmer, Julia) |
| Filing 24 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC (Fakhouri, Rami) |
| Filing 23 ATTORNEY Appearance for Defendants GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC by Rami N Fakhouri (Fakhouri, Rami) |
| Filing 22 MINUTE entry before the Honorable Elaine E. Bucklo: Per minute entry #18 dated 10/24/2023, a briefing schedule has been set on plaintiff's opposed motion and memorandum of law to remand pursuant to 28 U.S.C. 1447. Motion hearing set for 11/3/2023 is stricken, no appearance required. Mailed notice. (mgh, ) |
| Filing 21 NOTICE of Motion by Christopher Patrick Eby for presentment of extension of time, #20 before Honorable Elaine E. Bucklo on 11/3/2023 at 09:45 AM. (Eby, Christopher) |
| Filing 20 MOTION by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc. for extension of time (Opposed Motion to Extend Briefing Schedule on Plaintiff's Motion to Remand (Eby, Christopher) |
| Filing 19 ATTORNEY Appearance for Plaintiff Andrea Santiago by John Anthony Bruegger (Bruegger, John) |
| Filing 18 MINUTE entry before the Honorable Elaine E. Bucklo: Parties to take note of Judge Bucklo's motion call practice posted on her page at www.ilnd.uscourts.gov. Defendants' response to plaintiff's opposed motion and memorandum of law to remand pursuant to 28 U.S.C. 1447 #16 is due by 11/7/2023. Ruling set for 11/15/2023. The Court will issue a ruling by mail. Mailed notice. (mgh, ) |
| Filing 17 ATTORNEY Appearance for Defendant Pfizer, Inc. by Stephanie Ann Scharf (Scharf, Stephanie) |
| Filing 16 MOTION by Plaintiff Andrea Santiago to remand and Memorandum of Law (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit)(Bruegger, John) |
| Filing 15 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Pfizer, Inc. (Sax, George) |
| Filing 14 ATTORNEY Appearance for Defendant Pfizer, Inc. by George D Sax (Sax, George) |
| Filing 13 NOTICE by Andrea Santiago of Filing Opposition to Conditional Transfer Order (CTO-119) with JPML (Attachments: #1 Exhibit)(Bruegger, John) |
| Filing 12 MINUTE entry before the Honorable Elaine E. Bucklo: Removing Defendants' opposed motion to stay all proceedings pending transfer to multi-district litigation #10 is granted. Removing Defendants' opposed motion extend time to respond to plaintiff's complaint #8 is moot. This case is stayed until further order of the court. Status hearing set for 12/19/2023 at 9:45 a.m. (to track the case only, no appearance is required). The parties shall file a joint status report by 12/12/2023 and the court will enter an appropriate order. Mailed notice. (mgh, ) |
| Filing 11 NOTICE of Motion by Julia Ruth Zousmer for presentment of motion to stay, #10 before Honorable Elaine E. Bucklo on 10/4/2023 at 09:45 AM. (Zousmer, Julia) |
| Filing 10 MOTION by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc. to stay All Proceedings Pending Transfer to Multidistrict Litigation (Opposed) (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Zousmer, Julia) |
| Filing 9 NOTICE of Motion by Julia Ruth Zousmer for presentment of motion for extension of time to file answer, #8 before Honorable Elaine E. Bucklo on 10/4/2023 at 09:45 AM. (Zousmer, Julia) |
| Filing 8 MOTION by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc. for extension of time to file answer (Zousmer, Julia) |
| Filing 7 EXECUTIVE COMMITTEE ORDER: Case reassigned to the Honorable Elaine E. Bucklo for all further proceedings. Honorable Andrea R. Wood no longer assigned to the case pursuant to IOP 13(f)(1). Signed by Executive Committee on 09/22/2023. (daj, ) |
| Filing 6 ATTORNEY Appearance for Plaintiff Andrea Santiago by John Anthony Bruegger (Special and Limited Entry of Appearance) (Bruegger, John) |
| Filing 5 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation (Zousmer, Julia) |
| CASE ASSIGNED to the Honorable Andrea R. Wood. Designated as Magistrate Judge the Honorable Sheila M. Finnegan. Case assignment: Random assignment. (jxm, ) |
| Filing 4 ATTORNEY Appearance for Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation by Christopher Patrick Eby (Eby, Christopher) |
| Filing 3 ATTORNEY Appearance for Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation by Julia Ruth Zousmer (Zousmer, Julia) |
| Filing 2 CIVIL Cover Sheet (Zousmer, Julia) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2023-L-007883) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation Filing fee $ 402, receipt number AILNDC-21118522. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J)(Zousmer, Julia) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
